Potential lipolytic regulators derived from natural products as effective approaches to treat obesity.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2022
Historique:
received: 22 07 2022
accepted: 23 08 2022
entrez: 30 9 2022
pubmed: 1 10 2022
medline: 4 10 2022
Statut: epublish

Résumé

Epidemic obesity is contributing to increases in the prevalence of obesity-related metabolic diseases and has, therefore, become an important public health problem. Adipose tissue is a vital energy storage organ that regulates whole-body energy metabolism. Triglyceride degradation in adipocytes is called lipolysis. It is closely tied to obesity and the metabolic disorders associated with it. Various natural products such as flavonoids, alkaloids, and terpenoids regulate lipolysis and can promote weight loss or improve obesity-related metabolic conditions. It is important to identify the specific secondary metabolites that are most effective at reducing weight and the health risks associated with obesity and lipolysis regulation. The aims of this review were to identify, categorize, and clarify the modes of action of a wide diversity of plant secondary metabolites that have demonstrated prophylactic and therapeutic efficacy against obesity by regulating lipolysis. The present review explores the regulatory mechanisms of lipolysis and summarizes the effects and modes of action of various natural products on this process. We propose that the discovery and development of natural product-based lipolysis regulators could diminish the risks associated with obesity and certain metabolic conditions.

Identifiants

pubmed: 36176469
doi: 10.3389/fendo.2022.1000739
pmc: PMC9513423
doi:

Substances chimiques

Biological Products 0
Flavonoids 0
Terpenes 0
Triglycerides 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1000739

Informations de copyright

Copyright © 2022 Yang, Ge, Jiang and Yang.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Int J Mol Sci. 2021 Jul 28;22(15):
pubmed: 34360859
Eur J Pharmacol. 2017 Oct 15;813:84-93
pubmed: 28739087
J Med Food. 2019 Aug;22(8):753-770
pubmed: 31084513
Ann Nutr Metab. 2009;54(2):151-7
pubmed: 19390166
Diabetes. 2000 May;49(5):701-7
pubmed: 10905476
J Nutr Biochem. 2022 Jul;105:108998
pubmed: 35346829
Front Pharmacol. 2019 Jun 14;10:661
pubmed: 31258478
Cytokine. 2014 Oct;69(2):196-205
pubmed: 24993166
Nutr Metab (Lond). 2018 Jun 15;15:42
pubmed: 29946343
Biochim Biophys Acta. 2010 Sep;1801(9):1048-55
pubmed: 20435159
Front Endocrinol (Lausanne). 2021 Mar 09;12:627950
pubmed: 33767670
Nutrients. 2017 Jun 30;9(7):
pubmed: 28665330
Cells. 2021 Jun 11;10(6):
pubmed: 34208379
J Evid Based Complementary Altern Med. 2016 Jul;21(3):228-34
pubmed: 26269377
Phytother Res. 2009 Aug;23(8):1088-91
pubmed: 19107849
Adv Exp Med Biol. 2020;1276:197-222
pubmed: 32705602
Phytother Res. 2020 Dec;34(12):3298-3310
pubmed: 32614500
Cardiovasc Diabetol. 2015 Feb 13;14:22
pubmed: 25849380
Planta Med. 2014 Jul;80(11):880-6
pubmed: 24995500
Phytother Res. 2021 Feb;35(2):1113-1124
pubmed: 33015893
Curr Drug Metab. 2021;22(12):918-930
pubmed: 34325629
Cells. 2020 Nov 07;9(11):
pubmed: 33171828
Phytomedicine. 2012 Dec 15;20(1):3-8
pubmed: 23083815
Front Pharmacol. 2018 Nov 22;9:1366
pubmed: 30524290
Int J Obes Relat Metab Disord. 1999 Jan;23(1):98-105
pubmed: 10094584
Mol Med Rep. 2020 Jun;21(6):2603-2614
pubmed: 32323785
Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Oct;1862(10 Pt B):1221-1232
pubmed: 28754637
Cell. 2022 Feb 3;185(3):419-446
pubmed: 35120662
J Agric Food Chem. 2012 Jul 25;60(29):7262-9
pubmed: 22746947
Cytokine. 2008 Jan;41(1):29-37
pubmed: 18060802
Clin Sci (Lond). 2020 Mar 13;134(5):473-512
pubmed: 32149342
Exp Dermatol. 2013 Oct;22(10):638-43
pubmed: 24079732
Evid Based Complement Alternat Med. 2015;2015:298635
pubmed: 26413119
Pharmacol Res. 2020 Feb;152:104586
pubmed: 31877350
Endocrinology. 2013 Sep;154(9):2992-3000
pubmed: 23782940
Cell. 2012 Jul 20;150(2):366-76
pubmed: 22796012
Chem Biol Interact. 2019 Sep 25;311:108755
pubmed: 31319077
J Physiol Biochem. 2019 Feb;75(1):83-88
pubmed: 30539499
Arch Physiol Biochem. 2022 Feb;128(1):7-23
pubmed: 35143739
Molecules. 2019 Sep 27;24(19):
pubmed: 31569605
Biochem Biophys Res Commun. 2012 Apr 20;420(4):805-10
pubmed: 22465130
J Biol Chem. 2011 May 20;286(20):17467-77
pubmed: 21454566
Int J Mol Sci. 2020 Jan 07;21(2):
pubmed: 31936019
J Nutr Biochem. 2012 Apr;23(4):379-84
pubmed: 21543206
Autophagy. 2016;12(2):432-8
pubmed: 26902588
J Lipid Res. 2016 Jul;57(7):1243-55
pubmed: 27220352
J Clin Invest. 2008 Aug;118(8):2808-21
pubmed: 18654663
Nutr Res. 2015 Apr;35(4):317-27
pubmed: 25724338
Cell Mol Gastroenterol Hepatol. 2019;7(4):749-761
pubmed: 30763771
Biochim Biophys Acta Mol Cell Biol Lipids. 2022 Feb;1867(2):159071
pubmed: 34748972
Metab Syndr Relat Disord. 2020 Apr;18(3):146-153
pubmed: 31928504
J Cell Biochem. 2004 Apr 1;91(5):1021-9
pubmed: 15034936
Nat Rev Mol Cell Biol. 2008 May;9(5):367-77
pubmed: 18401346
Diabetes. 2002 Oct;51(10):2929-35
pubmed: 12351429
Arthritis Res Ther. 2012 Jun 12;14(3):R141
pubmed: 22691241
Food Chem Toxicol. 2012 Sep;50(9):3040-7
pubmed: 22721980
J Appl Physiol (1985). 2003 Feb;94(2):476-84
pubmed: 12391036
Int J Biochem Cell Biol. 2010 May;42(5):555-9
pubmed: 20025992
J Pharm Pharmacol. 2019 Sep;71(9):1429-1439
pubmed: 31259423
Endocrinology. 1990 Jun;126(6):2973-82
pubmed: 2161742
Int J Obes (Lond). 2008 Feb;32(2):283-91
pubmed: 17726433
Int J Biochem Cell Biol. 2016 Sep;78:149-155
pubmed: 27373682
Front Physiol. 2018 Jan 23;9:15
pubmed: 29410630
Biochem J. 2020 Mar 13;477(5):985-1008
pubmed: 32168372
Endocrinology. 1992 Jan;130(1):10-6
pubmed: 1370149
J Steroid Biochem Mol Biol. 2000 Dec 31;75(4-5):265-71
pubmed: 11282281
Food Chem Toxicol. 2019 Nov;133:110780
pubmed: 31449894
Phytother Res. 2012 Jul;26(7):1103-6
pubmed: 22114077
Nutrition. 2012 Oct;28(10):1055-62
pubmed: 22721876
Food Funct. 2020 Sep 23;11(9):7356-7370
pubmed: 32820787
Lipids Health Dis. 2016 Dec 9;15(1):214
pubmed: 27938388
Pharm Biol. 2015 Jun;53(6):870-5
pubmed: 25429790
Trends Endocrinol Metab. 2008 May-Jun;19(4):130-7
pubmed: 18337116
Biol Rev Camb Philos Soc. 2016 May;91(2):452-68
pubmed: 25740151
Science. 1993 Jan 1;259(5091):87-91
pubmed: 7678183
Molecules. 2020 Oct 28;25(21):
pubmed: 33126679
BMB Rep. 2018 May;51(5):249-254
pubmed: 29353597
Obesity (Silver Spring). 2009 Jul;17(7):1312-7
pubmed: 19214174
Biol Pharm Bull. 2018 Jul 1;41(7):985-993
pubmed: 29709897
Nutr Res Rev. 2014 Jun;27(1):63-93
pubmed: 24872083
J Nutr Biochem. 2012 Mar;23(3):218-27
pubmed: 21497077
Vopr Pitan. 2021;90(6):101-113
pubmed: 35032130
Biochim Biophys Acta. 2011 Apr;1812(4):527-35
pubmed: 20969954
Phytother Res. 2011 Mar;25(3):467-71
pubmed: 20830699
Phytother Res. 2011 Jun;25(6):935-9
pubmed: 21626599
Metabolism. 2015 Jul;64(7):826-36
pubmed: 25825274
Molecules. 2016 Dec 07;21(12):
pubmed: 27941615
Eur J Pharmacol. 2012 Aug 15;689(1-3):1-7
pubmed: 22659114
J Lipid Res. 2012 Nov;53(11):2296-306
pubmed: 22941773
J Lipid Res. 2011 Sep;52(9):1693-701
pubmed: 21743036
Biomed Pharmacother. 2020 Jul;127:110137
pubmed: 32353823
Int J Obes Relat Metab Disord. 2002 Nov;26(11):1442-50
pubmed: 12439645
Nat Cell Biol. 2015 Jun;17(6):759-70
pubmed: 25961502
Obesity (Silver Spring). 2008 Jul;16(7):1487-92
pubmed: 18451782
Cell Metab. 2011 Nov 2;14(5):612-22
pubmed: 22055504
Biosci Trends. 2018;12(6):587-594
pubmed: 30674760
Nutrition. 2018 Jun;50:82-90
pubmed: 29547798
Mol Nutr Food Res. 2010 Nov;54(11):1609-17
pubmed: 20521271
Nat Commun. 2021 Oct 8;12(1):5892
pubmed: 34625558
Diabetologia. 2008 Aug;51(8):1493-504
pubmed: 18528680
Molecules. 2018 Aug 10;23(8):
pubmed: 30103469
Traffic. 2020 Jan;21(1):94-105
pubmed: 31746121
J Diabetes. 2015 May;7(3):360-8
pubmed: 24981886
Mol Biol Rep. 2020 Apr;47(4):2703-2711
pubmed: 32180086
J Cell Mol Med. 2015 Jan;19(1):82-91
pubmed: 25381905
Obesity (Silver Spring). 2007 Nov;15(11):2571-82
pubmed: 18070748
Am J Physiol Regul Integr Comp Physiol. 2007 Jan;292(1):R77-85
pubmed: 16840650
Life Sci. 2022 Jun 1;298:120488
pubmed: 35331721
Exp Biol Med (Maywood). 2021 Jan;246(2):163-176
pubmed: 33045853
Biochem Biophys Res Commun. 2013 Feb 8;431(2):192-6
pubmed: 23313487
Life Sci. 2005 May 27;77(2):194-204
pubmed: 15862604
Biosci Biotechnol Biochem. 2005 Nov;69(11):2219-23
pubmed: 16306706
Circ J. 2020 Dec 25;85(1):2-8
pubmed: 33268604
C R Biol. 2006 Aug;329(8):598-607; discussion 653-5
pubmed: 16860278
J Physiol Biochem. 2013 Sep;69(3):585-93
pubmed: 23315205
Cell Metab. 2011 Jun 8;13(6):739-48
pubmed: 21641555
J Biol Chem. 1970 Sep 25;245(18):4849-51
pubmed: 4318482
Endocrinol Metab (Seoul). 2021 Oct;36(5):997-1006
pubmed: 34648704
Biomolecules. 2021 Nov 08;11(11):
pubmed: 34827648
Planta Med. 2010 Oct;76(15):1654-8
pubmed: 20425690
Obesity (Silver Spring). 2008 Jan;16(1):16-22
pubmed: 18223606
Nat Prod Res. 2020 Dec;34(23):3432-3436
pubmed: 30777451
Metabolism. 2016 May;65(5):646-654
pubmed: 27085773
Biofactors. 2016 Mar-Apr;42(2):201-11
pubmed: 26893251
Food Nutr Res. 2017 Jun 7;61(1):1330096
pubmed: 28659738
Endocrine. 2021 Dec;74(3):478-497
pubmed: 34625915
Life Sci. 2020 Feb 1;242:117212
pubmed: 31884092
Endocrinology. 2009 Nov;150(11):4892-900
pubmed: 19819972
Molecules. 2021 Apr 01;26(7):
pubmed: 33915783
Elife. 2022 Feb 09;11:
pubmed: 35138251
Clin Transl Med. 2021 Dec;11(12):e641
pubmed: 34911164
J Lipid Res. 2007 Jun;48(6):1253-62
pubmed: 17374880
Front Pharmacol. 2017 Feb 14;8:43
pubmed: 28261091
Am J Physiol Endocrinol Metab. 2015 Feb 15;308(4):E315-23
pubmed: 25516550
Phytother Res. 2020 Jun;34(6):1216-1225
pubmed: 31977122
Biomed Pharmacother. 2021 May;137:111315
pubmed: 33561645
J Nat Prod. 2014 Apr 25;77(4):744-50
pubmed: 24597820
BMC Complement Med Ther. 2021 Apr 22;21(1):128
pubmed: 33888116
Phytother Res. 2008 Nov;22(11):1434-9
pubmed: 18972582
Curr Gastroenterol Rep. 2017 Nov 9;19(12):61
pubmed: 29124370
Mol Cell Biochem. 2015 Dec;410(1-2):247-54
pubmed: 26359088
Eur J Pharmacol. 2018 Aug 5;832:81-89
pubmed: 29787773

Auteurs

Xi-Ding Yang (XD)

Department of Pharmacy, Second Xiangya Hospital of Central South University, Changsha, China.
Phase I Clinical Trial Center, The Second Xiangya Hospital of Central South University, Changsha, China.

Xing-Cheng Ge (XC)

Xiangxing College, Hunan University of Chinese Medicine, Changsha, China.

Si-Yi Jiang (SY)

Department of Pharmacy, Medical College, Yueyang Vocational Technical College, YueYang, China.

Yong-Yu Yang (YY)

Department of Pharmacy, Second Xiangya Hospital of Central South University, Changsha, China.
Hunan Provincial Engineering Research Central of Translational Medical and Innovative Drug, The Second Xiangya Hospital of Central South University, Changsha, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH